| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Substitutes | 10 | 2002 | 57 | 1.340 |
Why?
|
| Mitral Valve Insufficiency | 24 | 2020 | 1414 | 1.250 |
Why?
|
| Coronary Artery Bypass | 19 | 2023 | 2194 | 1.160 |
Why?
|
| Heart Valve Prosthesis Implantation | 12 | 2022 | 1569 | 1.040 |
Why?
|
| Aortic Valve Stenosis | 13 | 2022 | 2032 | 1.000 |
Why?
|
| Cardiopulmonary Bypass | 11 | 2021 | 1097 | 0.990 |
Why?
|
| Aortic Valve | 14 | 2022 | 1968 | 0.940 |
Why?
|
| Heart Valve Prosthesis | 14 | 2022 | 1468 | 0.880 |
Why?
|
| Cardiac Surgical Procedures | 18 | 2021 | 3682 | 0.820 |
Why?
|
| Aortic Valve Insufficiency | 5 | 2022 | 577 | 0.790 |
Why?
|
| Ultrafiltration | 1 | 2021 | 48 | 0.760 |
Why?
|
| Hemoglobins | 11 | 2002 | 1532 | 0.710 |
Why?
|
| Ventricular Function, Right | 7 | 2002 | 629 | 0.700 |
Why?
|
| Ventricular Dysfunction, Right | 5 | 2012 | 645 | 0.670 |
Why?
|
| Lightning | 1 | 2019 | 4 | 0.660 |
Why?
|
| Mitral Valve | 17 | 2019 | 1473 | 0.630 |
Why?
|
| Heart Valve Diseases | 6 | 2019 | 1033 | 0.600 |
Why?
|
| Heart Arrest, Induced | 1 | 2019 | 361 | 0.590 |
Why?
|
| Endocarditis | 4 | 2019 | 355 | 0.560 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2020 | 635 | 0.550 |
Why?
|
| Sternum | 2 | 2017 | 177 | 0.550 |
Why?
|
| Cardiomyopathy, Hypertrophic | 11 | 2018 | 1333 | 0.540 |
Why?
|
| Aortic Diseases | 2 | 2020 | 742 | 0.510 |
Why?
|
| Ventricular Remodeling | 10 | 2017 | 1280 | 0.510 |
Why?
|
| Hematoma | 1 | 2020 | 768 | 0.500 |
Why?
|
| Defibrillators, Implantable | 12 | 2015 | 1498 | 0.470 |
Why?
|
| Endocarditis, Bacterial | 4 | 2016 | 438 | 0.470 |
Why?
|
| Pericardium | 9 | 2010 | 679 | 0.460 |
Why?
|
| Coronary Vessels | 7 | 2023 | 3122 | 0.450 |
Why?
|
| Dogs | 35 | 2002 | 3847 | 0.440 |
Why?
|
| IgA Deficiency | 1 | 2013 | 39 | 0.440 |
Why?
|
| Diabetes Complications | 1 | 2020 | 1322 | 0.430 |
Why?
|
| Foreign-Body Migration | 1 | 2015 | 220 | 0.430 |
Why?
|
| Blood Component Transfusion | 2 | 2013 | 142 | 0.430 |
Why?
|
| Coronary Circulation | 15 | 1999 | 1617 | 0.420 |
Why?
|
| Sarcoma | 2 | 2019 | 1806 | 0.420 |
Why?
|
| Heart Septum | 5 | 2006 | 304 | 0.410 |
Why?
|
| Aortic Aneurysm | 6 | 2022 | 649 | 0.400 |
Why?
|
| Hypertension, Pulmonary | 8 | 2021 | 1605 | 0.360 |
Why?
|
| Thoracic Surgery | 2 | 2016 | 727 | 0.360 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2010 | 59 | 0.350 |
Why?
|
| Myocardial Infarction | 12 | 2022 | 11515 | 0.340 |
Why?
|
| Hemophilia A | 1 | 2013 | 359 | 0.340 |
Why?
|
| Coronary Disease | 15 | 2004 | 5926 | 0.330 |
Why?
|
| Hemodynamics | 20 | 2017 | 4202 | 0.320 |
Why?
|
| Chitosan | 1 | 2010 | 141 | 0.320 |
Why?
|
| Postoperative Complications | 29 | 2021 | 15880 | 0.320 |
Why?
|
| Myocardium | 8 | 2019 | 4788 | 0.320 |
Why?
|
| Sheep | 19 | 2015 | 1451 | 0.320 |
Why?
|
| Ventricular Function, Left | 13 | 2022 | 3941 | 0.310 |
Why?
|
| Myocardial Ischemia | 9 | 2013 | 2139 | 0.290 |
Why?
|
| Blood Transfusion | 7 | 2001 | 1308 | 0.280 |
Why?
|
| Atrial Fibrillation | 4 | 2021 | 5162 | 0.280 |
Why?
|
| Polyvinyl Alcohol | 3 | 2015 | 74 | 0.280 |
Why?
|
| Clinical Trials, Phase IV as Topic | 1 | 2006 | 30 | 0.260 |
Why?
|
| Endarterectomy | 2 | 2017 | 196 | 0.260 |
Why?
|
| Aprotinin | 1 | 2006 | 94 | 0.260 |
Why?
|
| Oxygen | 10 | 2001 | 4269 | 0.240 |
Why?
|
| Papillary Muscles | 5 | 2010 | 192 | 0.230 |
Why?
|
| Heart-Lung Machine | 1 | 2004 | 44 | 0.230 |
Why?
|
| Blood Loss, Surgical | 2 | 2013 | 643 | 0.220 |
Why?
|
| Ventricular Function | 3 | 2006 | 406 | 0.220 |
Why?
|
| Heart Neoplasms | 1 | 2007 | 374 | 0.220 |
Why?
|
| Heart-Assist Devices | 5 | 2012 | 1292 | 0.220 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 6551 | 0.210 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 2056 | 0.210 |
Why?
|
| Cardiac Pacing, Artificial | 7 | 2012 | 881 | 0.210 |
Why?
|
| Humans | 116 | 2023 | 768451 | 0.210 |
Why?
|
| Antifibrinolytic Agents | 1 | 2006 | 289 | 0.200 |
Why?
|
| Heart Diseases | 4 | 2010 | 2816 | 0.200 |
Why?
|
| Heart Transplantation | 6 | 2002 | 3291 | 0.200 |
Why?
|
| Sclerosing Solutions | 3 | 2006 | 79 | 0.200 |
Why?
|
| Echocardiography, Three-Dimensional | 10 | 2012 | 614 | 0.190 |
Why?
|
| Tachycardia, Ventricular | 5 | 2009 | 1309 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 5 | 2012 | 1095 | 0.190 |
Why?
|
| Ethanol | 5 | 2009 | 1334 | 0.180 |
Why?
|
| Aorta | 6 | 2020 | 2046 | 0.180 |
Why?
|
| Heart Failure | 11 | 2020 | 11857 | 0.180 |
Why?
|
| Hyaluronic Acid | 2 | 1994 | 489 | 0.180 |
Why?
|
| Thorax | 1 | 2023 | 559 | 0.180 |
Why?
|
| Pulmonary Embolism | 4 | 2021 | 2591 | 0.170 |
Why?
|
| Myocardial Revascularization | 3 | 2022 | 796 | 0.170 |
Why?
|
| Aorta, Thoracic | 3 | 1995 | 1107 | 0.170 |
Why?
|
| Treatment Outcome | 24 | 2022 | 65409 | 0.170 |
Why?
|
| Ventricular Pressure | 4 | 2002 | 210 | 0.160 |
Why?
|
| Polymers | 4 | 2017 | 1631 | 0.160 |
Why?
|
| Mortality | 2 | 2021 | 2917 | 0.160 |
Why?
|
| Echocardiography | 11 | 2018 | 5043 | 0.160 |
Why?
|
| Calcium Chloride | 2 | 1998 | 79 | 0.160 |
Why?
|
| Thoracotomy | 3 | 2017 | 375 | 0.160 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2022 | 308 | 0.160 |
Why?
|
| Blood Transfusion, Autologous | 2 | 2001 | 130 | 0.160 |
Why?
|
| Pacemaker, Artificial | 6 | 2015 | 828 | 0.150 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2020 | 145 | 0.150 |
Why?
|
| Bundle-Branch Block | 3 | 2016 | 278 | 0.150 |
Why?
|
| Splanchnic Circulation | 1 | 1998 | 119 | 0.150 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 2017 | 34 | 0.150 |
Why?
|
| Animals | 63 | 2020 | 169418 | 0.150 |
Why?
|
| Transplantation, Heterotopic | 1 | 1997 | 175 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2017 | 2145 | 0.140 |
Why?
|
| Erythrocyte Transfusion | 1 | 2002 | 574 | 0.140 |
Why?
|
| Thymus Gland | 1 | 2002 | 1267 | 0.140 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2018 | 278 | 0.140 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1943 | 0.140 |
Why?
|
| Tissue Adhesions | 3 | 2010 | 223 | 0.130 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2016 | 40 | 0.130 |
Why?
|
| Ion Channel Gating | 1 | 2018 | 429 | 0.130 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2002 | 1724 | 0.130 |
Why?
|
| Male | 85 | 2022 | 364781 | 0.130 |
Why?
|
| Learning Curve | 1 | 2017 | 233 | 0.130 |
Why?
|
| Endarterectomy, Carotid | 2 | 2005 | 558 | 0.130 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2007 | 193 | 0.130 |
Why?
|
| Transplantation, Homologous | 3 | 2008 | 4834 | 0.130 |
Why?
|
| Models, Cardiovascular | 3 | 1997 | 986 | 0.130 |
Why?
|
| Blood | 1 | 1998 | 597 | 0.120 |
Why?
|
| Hematocrit | 5 | 2002 | 625 | 0.120 |
Why?
|
| Hemothorax | 1 | 2015 | 58 | 0.120 |
Why?
|
| Mannitol | 3 | 1989 | 177 | 0.120 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2015 | 82 | 0.120 |
Why?
|
| Stroke Volume | 9 | 2022 | 5620 | 0.120 |
Why?
|
| Surgical Mesh | 1 | 2017 | 316 | 0.120 |
Why?
|
| Stents | 3 | 2003 | 3204 | 0.120 |
Why?
|
| Urticaria | 1 | 2015 | 151 | 0.110 |
Why?
|
| Ventricular Fibrillation | 3 | 2009 | 537 | 0.110 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 2126 | 0.110 |
Why?
|
| Prosthesis Failure | 4 | 2015 | 1208 | 0.110 |
Why?
|
| Foramen Ovale, Patent | 1 | 2016 | 210 | 0.110 |
Why?
|
| Heart Aneurysm | 1 | 1994 | 114 | 0.110 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 815 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 1997 | 684 | 0.110 |
Why?
|
| Norepinephrine | 3 | 1995 | 900 | 0.110 |
Why?
|
| Heart, Artificial | 2 | 2004 | 110 | 0.110 |
Why?
|
| Pericardial Effusion | 1 | 2015 | 246 | 0.110 |
Why?
|
| Myocardial Contraction | 6 | 2006 | 1527 | 0.110 |
Why?
|
| Aged | 48 | 2021 | 171520 | 0.110 |
Why?
|
| Bronchial Neoplasms | 1 | 2013 | 111 | 0.110 |
Why?
|
| Heart Ventricles | 8 | 2017 | 3839 | 0.100 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 1995 | 262 | 0.100 |
Why?
|
| Blood Pressure | 8 | 2012 | 8538 | 0.100 |
Why?
|
| Heart Conduction System | 1 | 2018 | 1009 | 0.100 |
Why?
|
| Intracranial Pressure | 1 | 1995 | 325 | 0.100 |
Why?
|
| Heart | 5 | 2023 | 4451 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 829 | 0.100 |
Why?
|
| Tetralogy of Fallot | 2 | 1988 | 628 | 0.100 |
Why?
|
| Oxygen Consumption | 6 | 1998 | 1882 | 0.100 |
Why?
|
| Time Factors | 18 | 2021 | 40271 | 0.100 |
Why?
|
| Microspheres | 3 | 1993 | 789 | 0.100 |
Why?
|
| Membranes, Artificial | 1 | 1994 | 367 | 0.100 |
Why?
|
| Cattle | 5 | 2002 | 3830 | 0.100 |
Why?
|
| Dyspnea | 3 | 2016 | 1352 | 0.100 |
Why?
|
| Aortic Rupture | 1 | 1995 | 322 | 0.100 |
Why?
|
| Blood Donors | 1 | 1994 | 345 | 0.100 |
Why?
|
| Chest Pain | 2 | 2016 | 1099 | 0.100 |
Why?
|
| Female | 76 | 2022 | 396943 | 0.100 |
Why?
|
| Cold Temperature | 1 | 2015 | 786 | 0.100 |
Why?
|
| Postoperative Hemorrhage | 3 | 2006 | 420 | 0.100 |
Why?
|
| Graft Survival | 1 | 2002 | 3890 | 0.090 |
Why?
|
| Anesthesia Recovery Period | 1 | 2012 | 155 | 0.090 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2013 | 259 | 0.090 |
Why?
|
| Follow-Up Studies | 21 | 2014 | 39430 | 0.090 |
Why?
|
| Ventilator Weaning | 1 | 2012 | 170 | 0.090 |
Why?
|
| Postoperative Care | 3 | 2017 | 1481 | 0.090 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2013 | 264 | 0.090 |
Why?
|
| Oxygenators | 2 | 2002 | 36 | 0.090 |
Why?
|
| Risk Factors | 22 | 2022 | 74915 | 0.090 |
Why?
|
| Heart Defects, Congenital | 2 | 2006 | 4713 | 0.090 |
Why?
|
| Aged, 80 and over | 20 | 2022 | 59680 | 0.090 |
Why?
|
| Pericardial Window Techniques | 1 | 2009 | 10 | 0.090 |
Why?
|
| Postpericardiotomy Syndrome | 1 | 2009 | 11 | 0.090 |
Why?
|
| Shock, Hemorrhagic | 1 | 1992 | 224 | 0.090 |
Why?
|
| Action Potentials | 1 | 2017 | 1837 | 0.090 |
Why?
|
| Solutions | 3 | 1998 | 411 | 0.080 |
Why?
|
| Plasma Substitutes | 1 | 1989 | 58 | 0.080 |
Why?
|
| Mitral Valve Stenosis | 1 | 2012 | 342 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2010 | 132 | 0.080 |
Why?
|
| Regional Blood Flow | 5 | 1998 | 1502 | 0.080 |
Why?
|
| Catheterization | 1 | 1995 | 1431 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 1997 | 2393 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 1509 | 0.080 |
Why?
|
| Cryosurgery | 1 | 1994 | 477 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2009 | 1568 | 0.080 |
Why?
|
| Bioprosthesis | 4 | 2002 | 592 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 2742 | 0.080 |
Why?
|
| Risk Assessment | 8 | 2019 | 24311 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2017 | 1683 | 0.080 |
Why?
|
| Collateral Circulation | 1 | 1989 | 293 | 0.080 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2017 | 353 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 16029 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 2430 | 0.070 |
Why?
|
| Pneumonectomy | 2 | 2013 | 1159 | 0.070 |
Why?
|
| Carotid Stenosis | 1 | 1995 | 864 | 0.070 |
Why?
|
| Tracheal Stenosis | 2 | 2002 | 228 | 0.070 |
Why?
|
| Heart Injuries | 1 | 2009 | 207 | 0.070 |
Why?
|
| Intraoperative Complications | 3 | 2003 | 1176 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 4 | 1995 | 1629 | 0.070 |
Why?
|
| Endocardial Cushion Defects | 1 | 1987 | 43 | 0.070 |
Why?
|
| Shock, Cardiogenic | 3 | 2004 | 711 | 0.070 |
Why?
|
| Blood Vessel Prosthesis | 4 | 1999 | 959 | 0.070 |
Why?
|
| Blood Coagulation | 1 | 2013 | 1162 | 0.070 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2009 | 248 | 0.070 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1998 | 1482 | 0.070 |
Why?
|
| Consensus | 1 | 2016 | 3207 | 0.070 |
Why?
|
| Survival Analysis | 9 | 2009 | 10125 | 0.070 |
Why?
|
| Omentum | 2 | 2003 | 168 | 0.070 |
Why?
|
| Chordae Tendineae | 1 | 2006 | 39 | 0.070 |
Why?
|
| Blood Volume | 2 | 2002 | 546 | 0.070 |
Why?
|
| Pancreas | 1 | 1993 | 1703 | 0.070 |
Why?
|
| Metabolomics | 1 | 2016 | 1675 | 0.070 |
Why?
|
| Middle Aged | 45 | 2018 | 223418 | 0.070 |
Why?
|
| Pulmonary Artery | 5 | 2021 | 1949 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2010 | 1765 | 0.070 |
Why?
|
| Rats, Inbred Strains | 2 | 2002 | 2087 | 0.070 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 2258 | 0.070 |
Why?
|
| Intra-Aortic Balloon Pumping | 6 | 2002 | 223 | 0.070 |
Why?
|
| Vasodilation | 4 | 1994 | 968 | 0.060 |
Why?
|
| Hypertrophy | 1 | 2008 | 562 | 0.060 |
Why?
|
| Heart Septal Defects | 1 | 1987 | 191 | 0.060 |
Why?
|
| Retrospective Studies | 25 | 2021 | 81834 | 0.060 |
Why?
|
| Echocardiography, Doppler | 4 | 2012 | 899 | 0.060 |
Why?
|
| Actuarial Analysis | 7 | 2005 | 372 | 0.060 |
Why?
|
| Length of Stay | 7 | 2020 | 6521 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2021 | 4840 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2020 | 3308 | 0.060 |
Why?
|
| Mitral Valve Prolapse | 1 | 2007 | 212 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 1994 | 1703 | 0.060 |
Why?
|
| Cardiac Output | 3 | 2006 | 838 | 0.060 |
Why?
|
| Severity of Illness Index | 6 | 2020 | 15965 | 0.060 |
Why?
|
| Solvents | 1 | 2006 | 298 | 0.060 |
Why?
|
| Abnormalities, Multiple | 2 | 1996 | 1424 | 0.060 |
Why?
|
| Sclerotherapy | 1 | 2006 | 183 | 0.060 |
Why?
|
| Hospital Mortality | 9 | 2020 | 5371 | 0.060 |
Why?
|
| Hydrogels | 1 | 2010 | 745 | 0.060 |
Why?
|
| Abscess | 1 | 2008 | 607 | 0.060 |
Why?
|
| Survival Rate | 11 | 2015 | 12875 | 0.060 |
Why?
|
| Injections | 3 | 2015 | 840 | 0.060 |
Why?
|
| Heart Block | 1 | 2005 | 390 | 0.060 |
Why?
|
| Multivariate Analysis | 9 | 2021 | 12096 | 0.060 |
Why?
|
| Hemodilution | 2 | 1995 | 120 | 0.050 |
Why?
|
| Surgical Wound Infection | 3 | 2002 | 1544 | 0.050 |
Why?
|
| Sympatholytics | 1 | 1982 | 82 | 0.050 |
Why?
|
| Prognosis | 10 | 2019 | 30028 | 0.050 |
Why?
|
| Exchange Transfusion, Whole Blood | 2 | 1995 | 59 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 2013 | 2959 | 0.050 |
Why?
|
| Chronic Disease | 6 | 2021 | 9382 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2016 | 20762 | 0.050 |
Why?
|
| Cardiac Tamponade | 1 | 2003 | 175 | 0.050 |
Why?
|
| Adult | 25 | 2019 | 223542 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 803 | 0.050 |
Why?
|
| Heart Arrest | 3 | 2002 | 1516 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2002 | 775 | 0.050 |
Why?
|
| Cardiovascular Agents | 1 | 2008 | 849 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 6537 | 0.050 |
Why?
|
| Tricuspid Valve Stenosis | 1 | 2001 | 26 | 0.050 |
Why?
|
| Heart Atria | 2 | 2006 | 1361 | 0.050 |
Why?
|
| Algorithms | 3 | 2019 | 14158 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 13026 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9425 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2004 | 916 | 0.040 |
Why?
|
| Ultrasonography | 4 | 2021 | 5995 | 0.040 |
Why?
|
| Electrocardiography | 6 | 2018 | 6410 | 0.040 |
Why?
|
| Vascular Resistance | 3 | 1995 | 941 | 0.040 |
Why?
|
| Reoperation | 8 | 2005 | 4342 | 0.040 |
Why?
|
| Cohort Studies | 7 | 2022 | 41797 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2001 | 2257 | 0.040 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2003 | 350 | 0.040 |
Why?
|
| Adenosine | 2 | 1987 | 816 | 0.040 |
Why?
|
| Methemoglobin | 1 | 1998 | 25 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 1989 | 2102 | 0.040 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2002 | 374 | 0.040 |
Why?
|
| Surgical Flaps | 2 | 2003 | 1683 | 0.040 |
Why?
|
| Device Removal | 1 | 2003 | 641 | 0.040 |
Why?
|
| Chromonar | 3 | 1994 | 4 | 0.040 |
Why?
|
| Disease Models, Animal | 8 | 2017 | 18388 | 0.040 |
Why?
|
| Partial Pressure | 1 | 1998 | 247 | 0.040 |
Why?
|
| Treatment Failure | 3 | 2006 | 2656 | 0.040 |
Why?
|
| Sheep, Domestic | 1 | 2017 | 52 | 0.040 |
Why?
|
| Electric Countershock | 2 | 1993 | 534 | 0.040 |
Why?
|
| Death | 1 | 2022 | 683 | 0.040 |
Why?
|
| Rats | 4 | 2002 | 23839 | 0.040 |
Why?
|
| Veins | 1 | 2002 | 767 | 0.040 |
Why?
|
| Digestive System | 1 | 1998 | 244 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2018 | 321 | 0.040 |
Why?
|
| Logistic Models | 4 | 2016 | 13324 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2017 | 2994 | 0.040 |
Why?
|
| Disease Management | 1 | 2008 | 2533 | 0.030 |
Why?
|
| Trachea | 2 | 2002 | 1095 | 0.030 |
Why?
|
| Acute Disease | 5 | 2016 | 7246 | 0.030 |
Why?
|
| Anemia | 2 | 2002 | 1521 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2009 | 2258 | 0.030 |
Why?
|
| Linear Models | 2 | 2017 | 5880 | 0.030 |
Why?
|
| Blood Flow Velocity | 2 | 1999 | 1377 | 0.030 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2001 | 362 | 0.030 |
Why?
|
| Swine | 2 | 1997 | 5996 | 0.030 |
Why?
|
| Phenylephrine | 3 | 1982 | 294 | 0.030 |
Why?
|
| Equipment Design | 3 | 2017 | 3530 | 0.030 |
Why?
|
| Prosthesis Implantation | 2 | 2015 | 595 | 0.030 |
Why?
|
| Cyanosis | 1 | 1996 | 82 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2005 | 8559 | 0.030 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 1999 | 709 | 0.030 |
Why?
|
| Methemoglobinemia | 1 | 1995 | 45 | 0.030 |
Why?
|
| Constriction | 1 | 1995 | 168 | 0.030 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2019 | 530 | 0.030 |
Why?
|
| Prosthesis Design | 3 | 2012 | 2126 | 0.030 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 1994 | 109 | 0.030 |
Why?
|
| Diastole | 2 | 1994 | 784 | 0.030 |
Why?
|
| Pancreatitis | 2 | 1991 | 1087 | 0.030 |
Why?
|
| Erythropoietin | 1 | 1997 | 719 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 1998 | 1126 | 0.030 |
Why?
|
| Postoperative Period | 3 | 1993 | 1833 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2016 | 9687 | 0.030 |
Why?
|
| Endocardium | 1 | 1994 | 249 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 2226 | 0.030 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1995 | 452 | 0.030 |
Why?
|
| Amylases | 2 | 1991 | 171 | 0.030 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 12561 | 0.030 |
Why?
|
| Electrophysiology | 2 | 1993 | 1266 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 1563 | 0.030 |
Why?
|
| Registries | 2 | 2020 | 8373 | 0.030 |
Why?
|
| Vasoconstriction | 2 | 1993 | 594 | 0.030 |
Why?
|
| Back Pain | 1 | 2016 | 547 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2012 | 1244 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 10358 | 0.030 |
Why?
|
| Tachycardia | 1 | 1994 | 599 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 998 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 2 | 1997 | 1487 | 0.020 |
Why?
|
| Perfusion | 2 | 1995 | 1402 | 0.020 |
Why?
|
| Cardiac Output, Low | 2 | 1983 | 191 | 0.020 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1992 | 141 | 0.020 |
Why?
|
| Haplotypes | 1 | 2018 | 2725 | 0.020 |
Why?
|
| Cause of Death | 6 | 2001 | 3727 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 3438 | 0.020 |
Why?
|
| Paraplegia | 1 | 1992 | 161 | 0.020 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2003 | 216 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 1994 | 477 | 0.020 |
Why?
|
| Recurrence | 4 | 2008 | 8510 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 2016 | 690 | 0.020 |
Why?
|
| Incidence | 4 | 2015 | 21552 | 0.020 |
Why?
|
| Peptic Ulcer | 1 | 1992 | 222 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2002 | 12450 | 0.020 |
Why?
|
| Serum Albumin | 2 | 1992 | 676 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 15460 | 0.020 |
Why?
|
| Catheter Ablation | 3 | 2009 | 2775 | 0.020 |
Why?
|
| Propensity Score | 1 | 2017 | 1971 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 2127 | 0.020 |
Why?
|
| Lacrimal Apparatus | 1 | 1972 | 223 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6242 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2016 | 1320 | 0.020 |
Why?
|
| Dipyridamole | 1 | 1989 | 143 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1585 | 0.020 |
Why?
|
| Pericardiectomy | 1 | 2009 | 45 | 0.020 |
Why?
|
| Hypertension | 2 | 1981 | 8611 | 0.020 |
Why?
|
| Fontan Procedure | 1 | 1996 | 805 | 0.020 |
Why?
|
| Biological Transport | 1 | 1994 | 2089 | 0.020 |
Why?
|
| Particle Size | 1 | 1993 | 1654 | 0.020 |
Why?
|
| Pulmonary Circulation | 2 | 1993 | 744 | 0.020 |
Why?
|
| Methyltransferases | 1 | 1972 | 375 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2019 | 2239 | 0.020 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 1999 | 1460 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 692 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1255 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2018 | 2594 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 1668 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 2204 | 0.020 |
Why?
|
| Bicarbonates | 1 | 1989 | 292 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1989 | 659 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1995 | 1439 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 2 | 2006 | 952 | 0.020 |
Why?
|
| Nitroglycerin | 1 | 1989 | 332 | 0.020 |
Why?
|
| United States | 1 | 2016 | 73121 | 0.020 |
Why?
|
| Pressure | 3 | 2006 | 1173 | 0.020 |
Why?
|
| Half-Life | 1 | 1989 | 650 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 1987 | 100 | 0.020 |
Why?
|
| Comorbidity | 2 | 2008 | 10601 | 0.020 |
Why?
|
| Arterial Occlusive Diseases | 2 | 1982 | 751 | 0.020 |
Why?
|
| Gels | 1 | 2008 | 421 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1992 | 1152 | 0.020 |
Why?
|
| Ventricular Septum | 1 | 2007 | 76 | 0.020 |
Why?
|
| Resuscitation | 1 | 1992 | 680 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2008 | 195 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1991 | 1056 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1995 | 1814 | 0.020 |
Why?
|
| Systole | 2 | 1995 | 938 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 1525 | 0.020 |
Why?
|
| Polycythemia | 1 | 1987 | 124 | 0.020 |
Why?
|
| Polysaccharides | 1 | 1973 | 1024 | 0.020 |
Why?
|
| Ischemia | 1 | 1995 | 1900 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9361 | 0.020 |
Why?
|
| Zebrafish | 1 | 2017 | 3038 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 2010 | 755 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1992 | 839 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 1170 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1992 | 945 | 0.020 |
Why?
|
| Debridement | 1 | 2008 | 494 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2006 | 281 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 394 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1992 | 813 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2010 | 1209 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3637 | 0.020 |
Why?
|
| Dependovirus | 1 | 2010 | 720 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1994 | 2422 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1994 | 6353 | 0.010 |
Why?
|
| Gestational Age | 1 | 2013 | 3615 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 13708 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1981 | 2488 | 0.010 |
Why?
|
| Tricuspid Valve | 1 | 1987 | 419 | 0.010 |
Why?
|
| Cardiac Volume | 2 | 2001 | 197 | 0.010 |
Why?
|
| Hypotension, Controlled | 1 | 1983 | 16 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1993 | 2146 | 0.010 |
Why?
|
| Models, Animal | 1 | 2010 | 2126 | 0.010 |
Why?
|
| Creatinine | 1 | 1989 | 1915 | 0.010 |
Why?
|
| Constriction, Pathologic | 2 | 1993 | 1103 | 0.010 |
Why?
|
| Infant | 5 | 2002 | 36497 | 0.010 |
Why?
|
| Referral and Consultation | 2 | 2012 | 3629 | 0.010 |
Why?
|
| Physiology | 1 | 1984 | 112 | 0.010 |
Why?
|
| Adolescent | 7 | 2006 | 89168 | 0.010 |
Why?
|
| Wounds, Gunshot | 1 | 2009 | 589 | 0.010 |
Why?
|
| Cell Line | 1 | 2017 | 15609 | 0.010 |
Why?
|
| Heart Murmurs | 1 | 2003 | 92 | 0.010 |
Why?
|
| Staphylococcal Infections | 2 | 2006 | 1412 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2007 | 835 | 0.010 |
Why?
|
| Mediastinitis | 1 | 2003 | 49 | 0.010 |
Why?
|
| Electrodes, Implanted | 3 | 1993 | 841 | 0.010 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2003 | 49 | 0.010 |
Why?
|
| Patient Selection | 2 | 2007 | 4266 | 0.010 |
Why?
|
| Phentolamine | 1 | 1982 | 102 | 0.010 |
Why?
|
| Massachusetts | 1 | 2016 | 8908 | 0.010 |
Why?
|
| Esophageal Perforation | 1 | 2003 | 65 | 0.010 |
Why?
|
| Equipment Safety | 1 | 2004 | 250 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1982 | 181 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2008 | 2932 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1984 | 516 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1991 | 1891 | 0.010 |
Why?
|
| Forecasting | 3 | 1998 | 2950 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1982 | 174 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1994 | 1937 | 0.010 |
Why?
|
| Renal Insufficiency | 2 | 1998 | 809 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1982 | 177 | 0.010 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 1982 | 164 | 0.010 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1982 | 244 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1993 | 10784 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2007 | 36840 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4138 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2006 | 1680 | 0.010 |
Why?
|
| Chemistry | 1 | 1981 | 327 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1981 | 486 | 0.010 |
Why?
|
| Propranolol | 1 | 1982 | 493 | 0.010 |
Why?
|
| Thoracic Neoplasms | 1 | 2003 | 270 | 0.010 |
Why?
|
| Syncope | 1 | 2003 | 430 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2863 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2006 | 1006 | 0.010 |
Why?
|
| Freezing | 1 | 1981 | 311 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1981 | 384 | 0.010 |
Why?
|
| Blood Circulation | 1 | 1980 | 248 | 0.010 |
Why?
|
| Catecholamines | 1 | 1980 | 390 | 0.010 |
Why?
|
| Prospective Studies | 6 | 2008 | 54914 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5803 | 0.010 |
Why?
|
| Lung | 2 | 2016 | 10090 | 0.010 |
Why?
|
| Prevalence | 1 | 2016 | 15880 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 14728 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 11249 | 0.010 |
Why?
|
| Insulin | 1 | 1973 | 6606 | 0.010 |
Why?
|
| Lipase | 2 | 1991 | 321 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1991 | 4505 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1977 | 82 | 0.010 |
Why?
|
| Epoetin Alfa | 1 | 1997 | 78 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1977 | 306 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2882 | 0.010 |
Why?
|
| Drainage | 1 | 2003 | 1179 | 0.010 |
Why?
|
| Hyperemia | 1 | 1979 | 225 | 0.010 |
Why?
|
| Morbidity | 1 | 2003 | 1760 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1977 | 398 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 1982 | 913 | 0.010 |
Why?
|
| Corynebacterium Infections | 1 | 1997 | 27 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1994 | 9066 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2008 | 2823 | 0.010 |
Why?
|
| Laser Therapy | 1 | 2003 | 1107 | 0.010 |
Why?
|
| Dextrocardia | 1 | 1996 | 37 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1992 | 4362 | 0.010 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2001 | 640 | 0.010 |
Why?
|
| Methods | 1 | 1996 | 1067 | 0.010 |
Why?
|
| Situs Inversus | 1 | 1996 | 63 | 0.010 |
Why?
|
| Aorta, Abdominal | 2 | 1991 | 627 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2006 | 2785 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1986 | 3783 | 0.010 |
Why?
|
| Hepatic Veins | 1 | 1996 | 112 | 0.010 |
Why?
|
| Replantation | 1 | 1997 | 145 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1981 | 1629 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2008 | 22293 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 1980 | 756 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 5793 | 0.010 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 1998 | 326 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2003 | 1207 | 0.010 |
Why?
|
| Candidiasis | 1 | 1997 | 367 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2002 | 1162 | 0.010 |
Why?
|
| Models, Biological | 1 | 1990 | 9505 | 0.010 |
Why?
|
| Lung Transplantation | 1 | 2003 | 1310 | 0.010 |
Why?
|
| Pregnancy | 2 | 2013 | 30179 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 1973 | 157 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1996 | 993 | 0.010 |
Why?
|
| Chromatography, Paper | 1 | 1972 | 76 | 0.010 |
Why?
|
| Radiation Effects | 1 | 1972 | 73 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 1997 | 619 | 0.010 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1972 | 94 | 0.010 |
Why?
|
| Sex Factors | 2 | 1998 | 10647 | 0.010 |
Why?
|
| Isoamylase | 1 | 1991 | 10 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 1993 | 320 | 0.010 |
Why?
|
| Mathematics | 2 | 1984 | 704 | 0.010 |
Why?
|
| Wound Healing | 1 | 2003 | 2819 | 0.010 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1994 | 489 | 0.010 |
Why?
|
| Arteries | 1 | 1996 | 1126 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2003 | 4526 | 0.010 |
Why?
|
| Anti-Ulcer Agents | 1 | 1992 | 112 | 0.010 |
Why?
|
| Lactates | 2 | 1983 | 401 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 1991 | 112 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1972 | 459 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1972 | 527 | 0.010 |
Why?
|
| Carotid Artery Diseases | 1 | 1997 | 879 | 0.010 |
Why?
|
| Pineal Gland | 1 | 1972 | 158 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 1948 | 0.010 |
Why?
|
| Child, Preschool | 3 | 2002 | 42623 | 0.010 |
Why?
|
| Histamine H2 Antagonists | 1 | 1992 | 169 | 0.010 |
Why?
|
| S-Adenosylmethionine | 1 | 1972 | 220 | 0.010 |
Why?
|
| Acetates | 1 | 1972 | 318 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 82045 | 0.010 |
Why?
|
| Spleen | 1 | 1996 | 2298 | 0.010 |
Why?
|
| Iliac Artery | 1 | 1991 | 344 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 1993 | 1170 | 0.010 |
Why?
|
| Syndrome | 1 | 1996 | 3278 | 0.010 |
Why?
|
| Antibodies | 1 | 1997 | 2425 | 0.010 |
Why?
|
| Manganese | 1 | 1972 | 394 | 0.000 |
Why?
|
| Infant, Newborn | 2 | 2002 | 26395 | 0.000 |
Why?
|
| Attitude to Health | 1 | 1997 | 2030 | 0.000 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 1995 | 1092 | 0.000 |
Why?
|
| Vasodilator Agents | 1 | 1993 | 991 | 0.000 |
Why?
|
| Magnesium | 1 | 1972 | 816 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1994 | 2362 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 6527 | 0.000 |
Why?
|
| Hospitalization | 2 | 1998 | 10845 | 0.000 |
Why?
|
| Bronchial Fistula | 1 | 1988 | 83 | 0.000 |
Why?
|
| Zinc | 1 | 1972 | 677 | 0.000 |
Why?
|
| Mediastinal Diseases | 1 | 1988 | 91 | 0.000 |
Why?
|
| Reproducibility of Results | 2 | 1997 | 20231 | 0.000 |
Why?
|
| Lung Diseases | 1 | 1997 | 1926 | 0.000 |
Why?
|
| Pleural Diseases | 1 | 1988 | 138 | 0.000 |
Why?
|
| Serotonin | 1 | 1972 | 1047 | 0.000 |
Why?
|
| Blood Viscosity | 1 | 1987 | 125 | 0.000 |
Why?
|
| Femoral Artery | 1 | 1991 | 829 | 0.000 |
Why?
|
| Amiodarone | 1 | 1988 | 217 | 0.000 |
Why?
|
| Safety | 1 | 1991 | 1159 | 0.000 |
Why?
|
| Probability | 1 | 1992 | 2483 | 0.000 |
Why?
|
| Fistula | 1 | 1988 | 213 | 0.000 |
Why?
|
| Disease Progression | 1 | 2003 | 13655 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1972 | 3594 | 0.000 |
Why?
|
| Heart Rate | 1 | 1977 | 4218 | 0.000 |
Why?
|
| Light | 1 | 1972 | 1357 | 0.000 |
Why?
|
| Equipment Failure | 1 | 1988 | 585 | 0.000 |
Why?
|
| Age Factors | 1 | 2002 | 18478 | 0.000 |
Why?
|
| Emergencies | 1 | 1992 | 1222 | 0.000 |
Why?
|
| Patient Satisfaction | 1 | 1997 | 3484 | 0.000 |
Why?
|
| Homeostasis | 2 | 1987 | 3351 | 0.000 |
Why?
|
| Aortography | 1 | 1986 | 422 | 0.000 |
Why?
|
| Stress, Physiological | 1 | 1992 | 1409 | 0.000 |
Why?
|
| Trimethaphan | 1 | 1983 | 11 | 0.000 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 1983 | 66 | 0.000 |
Why?
|
| Indoles | 1 | 1972 | 1834 | 0.000 |
Why?
|
| Halothane | 1 | 1983 | 200 | 0.000 |
Why?
|
| Iron | 1 | 1972 | 1813 | 0.000 |
Why?
|
| Technetium | 1 | 1983 | 326 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 60045 | 0.000 |
Why?
|
| Stroke | 1 | 2004 | 9791 | 0.000 |
Why?
|
| Hydrostatic Pressure | 1 | 1982 | 99 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1983 | 585 | 0.000 |
Why?
|
| Radiography | 1 | 1992 | 6995 | 0.000 |
Why?
|
| Child | 2 | 2002 | 80863 | 0.000 |
Why?
|
| Peptides | 1 | 1991 | 4368 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1983 | 1998 | 0.000 |
Why?
|
| Uterus | 1 | 1982 | 660 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 1992 | 3805 | 0.000 |
Why?
|
| Lactic Acid | 1 | 1983 | 1140 | 0.000 |
Why?
|
| Epinephrine | 1 | 1980 | 795 | 0.000 |
Why?
|
| Liver | 1 | 1992 | 7575 | 0.000 |
Why?
|
| Dopamine | 1 | 1980 | 1616 | 0.000 |
Why?
|
| Anesthesia | 1 | 1982 | 1596 | 0.000 |
Why?
|